Search results

Source:

Public Health England - PHE (Add filter)

Source:

NHS England (Remove filter)

Published by NHS England;Public Health England, 01 May 2017

The data and information presented in each of the atlases do not always explain the reason for the variation, however the strength and power of the atlas series is in the questions they raise about...

Read Summary

Type:

Prescribing and Technical Information (Remove filter)

Source:

Department of Health (Remove filter)

Published by Department of Health, 29 March 2019

This is the first annual review of the regulations relating to the statutory scheme for branded medicines pricing, which came into force on 1 April 2018.

Read Summary

Type:

Prescribing and Technical Information (Remove filter)

Source:

NICE Quality and Productivity Case Studies (Remove filter)

Published by Queen's University Belfast, 17 November 2014

NICE summary of review conclusions Antigen-specific active immunotherapy for ovarian cancer is not supported by sufficient good quality evidence. Consideration could be given to using it only...

Read Summary

Type:

Case Studies (Add filter)

Type:

Quality Indicators (Remove filter)

Source:

European Commission (Remove filter)

Published by European Commission, 01 March 2017

Measuring integration is different from measuring the performance of integrated care. This report addresses this dual challenge: on the one hand it focuses on design principles, building...

Read Summary

Type:

Primary Research (Add filter)

Type:

Evidence Summaries (Add filter)

Type:

Quality Indicators (Remove filter)

Source:

NHS England (Remove filter)

Published by NHS England, 01 May 2016

May 2016 heat maps - Medical technologies at CCG level. The information is presented in a heat map to provide a graphical representation of the data on medicines. Data can be used to compare...

Read Summary

Type:

Prescribing and Technical Information (Remove filter)

Source:

NHS England (Remove filter)

Published by NHS England, 11 March 2019

This guidance document provides information on changes to the law relating to the reclassification of the drugs pregabalin and gabapentin.

SPS comment

Type:

Prescribing and Technical Information (Remove filter)

Source:

NHS England (Remove filter)

Published by NHS England, 21 June 2019

This national dose banding table is to be used by hospital trust pharmacy teams to ensure a standard approach to dose banding of chemotherapy across all hospital trusts. The table is intended to be...

Read Summary

Type:

Prescribing and Technical Information (Remove filter)